The 7-OH Ban
The 7-OH Ban

Challenging Pathos

In this episode of The Needle and the Narrative, we discuss the upcoming 7-OH ban by the DEA and the federal government. Tina Kasson of Challenges Inc SC has done extensive research to help educate the public on these substacnces and is actively...

InformativeHonestAuthenticSupportiveHopeful

51:24•30 Jul 2026

RSS Feed

The 7-OH Ban, Kratom, and Why Prohibition Backfires

Episode Overview

Kratom and 7-OH are used by many people for pain, mental health, and opioid withdrawal, and most reported overdoses involve multiple substances rather than kratom or 7-OH alone.
The DEA’s temporary Schedule I ban on 7-OH removes regulatory oversight, pushing supply into illicit markets and likely increasing overdose risk through adulterated products.
South Carolina’s Kratom Consumer Protection Act already requires age limits, behind-the-counter sales, and proper labelling, showing how regulation can offer safeguards without full bans.
Significant misinformation about kratom and 7-OH is being repeated in official trainings and media, so harm reductionists emphasise evidence-based education for both providers and people who use drugs.
Harm reduction work focuses on acknowledging both benefits and risks of substances, reducing harm rather than eliminating it, and centring the voices and experiences of people who use drugs.

““We’re harm reduction, we’re not harm elimination.””

What can we learn from those who have battled addiction? This conversation from Challenging Pathos’ series The Needle and the Narrative zeroes in on the looming federal “7-OH” ban and what it could mean for people who use drugs, chronic pain patients, and harm reduction workers. Host Chris Stepp sits down with harm reductionist and researcher Tina Kasson from Challenges Inc SC, who has been “spending, geez, like months now” building an evidence-based presentation on kratom and 7-OH.

Together they chat through what kratom actually is, how 7-OH differs as a semi-synthetic, and why “options and information” matter so much for people trying to manage pain, mental health, or opioid withdrawal. You’ll hear Tina explain how most so-called “kratom overdoses” involve polysubstance use, why a rat study got wildly overused to claim 7-OH is “20 times more potent than morphine”, and how the DEA’s temporary Schedule I move creates a legal grey zone that’s hard to challenge.

Chris and Tina stress that once 7-OH is pushed underground, “we lose all regulatory control”, with a real risk of adulterated products and a surge in overdose deaths. There’s also sharp criticism of misinformation spreading through official trainings, plus some uncomfortable honesty about how bans often track more with money and lobbying than with genuine public health concerns.

At the same time, they keep circling back to harm reduction basics: acknowledge both benefits and risks, focus on education, and let adults make informed choices rather than punish them for using drugs. If you’re curious about how drug policy, stigma, and everyday survival collide on the ground in South Carolina, this chat offers a blunt, research-heavy, but very human perspective. It might leave you asking: are bans really about safety, or about control?

PreviousMiami INHSU HCV Symposium